EQRx logo

EQRx

EQRx (Nasdaq: EQRX or EQRXW) is a first-of-a-kind company that is revolutionizing the way medicines are discovered, developed, and brought to people.

eqrx.com
Cambridge, MA

CEO: Alexis Borisy
Arboretum Lead: Jan Garfinkle

IN THE NEWS
June 14, 2022 in EQRx, News Page

EQRx Announces Acceptance of Market Authorization Application by the UK’s MHRA

EQRx, Inc. (Nasdaq: EQRX), a new type of pharmaceutical company committed to developing and delivering innovative medicines to patients at radically lower prices, today announced that the United Kingdom (U.K.)’s Medicines…
Read More
May 27, 2022 in EQRx, News Page

EQRx Announces New Data for Lead Oncology Programs

EQRx, Inc. (Nasdaq: EQRX), a new type of pharmaceutical company committed to developing and delivering innovative medicines to patients at radically lower prices, today announced data from pivotal trials of sugemalimab,…
Read More
March 23, 2022 in EQRx, News Page

EQRx Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Corporate Progress

EQRx, Inc. (Nasdaq: EQRX), a new type of pharmaceutical company committed to developing and delivering innovative medicines to patients at radically lower prices, today reported financial results for the quarter and…
Read More
January 18, 2022 in EQRx, News Page

EQRx Announces Two Lancet Oncology Publications of Positive Phase 3 Results

EQRx, Inc. (Nasdaq: EQRX) a new type of pharmaceutical company committed to developing and delivering important new medicines to patients at radically lower prices, today announced that data from its…
Read More